Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness

Completed · Not applicable

Conditions studied: Tobacco Cessation

In brief

All patients with serious mental illness are abstinent while in the hospital for a psychiatric admission yet almost all return to smoking after discharge. The investigators propose to test a digital intervention adapted to the needs of SMI smokers and to being introduced in the inpatient psychiatric setting. Such an intervention could bridge the inpatient to outpatient gap in cessation services and will help people remain abstinent following hospital discharge.

Key facts

Study ID

NCT04367506

Run by

University of Maryland, Baltimore

People needed

59

Starts

2022-09-06

Expected to finish

2024-03-25

Last updated by the study team

2026-07-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 or greater
• Diagnosis of serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression)
• Current smoker [prior to admission, smoked at least one cigarette or small cigar per day in the past month (unless restricted, e.g. due to ER/hospital visit) and smoked at least 100 cigarettes lifetime]
• Interested in remaining quit after hospital discharge or quitting within the following 30 days
• Expected Internet use at least 3 times/week post-discharge and ownership of mobile device with text messaging plan post-discharge.
• Discharge destination within 1-hour of SPH given that Aim 3 involves biochemical verification (carbon monoxide testing).
• Reading competence as demonstrated by a score of >= 37 on the Word Reading subtest of the Wide Range Achievement Test - 4th Edition (WRAT-4)168 to ensure the ability to engage in the intervention.

You may not qualify if…

• Intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness.
• Homeless prior to admission or anticipated to be homeless at discharge.
• Discharge to a residential setting where smoking is prohibited.
• Medical condition for which the use of nicotine replacement therapy (NRT) is contraindicated including pregnant, planning to become pregnant, or breastfeeding; within 4 weeks post myocardial infarction; severe arrhythmia, severe angina pectoris; peptic ulcer; severe renal failure; poorly controlled insulin-dependent diabetes; severely uncontrolled hypertension; peripheral vascular disease.

Where it is running

• Melanie Bennett — Baltimore, Maryland, United States
• University of Maryland School of Medicine — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.